iRT Systems GmbH

iRT Systems GmbH manufactures the Integral Quality Monitor (IQM) System, a real-time verification device for radiation therapy treatment delivery. The IQM System represents a paradigm shift in radiation therapy quality assurance by providing fully automated, real-time verification of complex treatment techniques without user intervention. The device integrates seamlessly into clinical workflows and performs independent verification of beam product quality and treatment plan delivery. IQM is designed to reduce quality assurance time while maintaining or exceeding the error detection capability of conventional 3D phantom-based methods. The system has been clinically evaluated at leading radiation oncology centers worldwide, including Johns Hopkins University, University of California at Davis, Princess Margaret Cancer Centre, and multiple European institutions. The device complies with EU regulatory requirements, including the 2013/59/EURATOM directive on radiation protection. iRT Systems serves radiation oncology departments and cancer centers globally, with reference sites across North America and Europe. The company actively participates in major oncology conferences including ESTRO, AAPM, DEGRO, and ICON, demonstrating commitment to clinical education and advancement of radiation therapy quality standards.